86 results
Page 2 of 5
POS AM
yp8m1nen tf
24 Mar 21
Prospectus update (post-effective amendment)
9:17am
8-K
EX-99.1
qqc69qumc6dj2h697dv
23 Mar 21
GeoVax Reports 2020 Year-End Financial Results
4:35pm
8-K
EX-99.1
lkg7q
11 Feb 21
GeoVax Announces Closing of $10.3 Million Bought Deal Offering
2:35pm
8-K
EX-99.1
m96cl0k7u9hsq8uf7f
11 Feb 21
GeoVax Announces Pricing of $9.0 Million Bought Deal Offering
9:21am
424B5
ar8k vrj2
11 Feb 21
Prospectus supplement for primary offering
9:17am
8-K
EX-99.1
68o70 o5i3x9
30 Nov 20
GeoVax Announces License Agreement with NIH to Support Continued Advancements in Vaccine Development
5:18pm
8-K
EX-99.1
ji21b10b
5 Nov 20
GeoVax Reports 2020 Third Quarter Financial Results
5:18pm
424B3
ewq6rir9xsf8i
5 Nov 20
Prospectus supplement
5:17pm
8-K
EX-99.1
b5sytat1l1y
26 Oct 20
GeoVax Announces License Agreement with NIH
5:28pm
8-K
EX-99.1
w16 s52ekajyz
29 Sep 20
GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq
5:24pm
424B4
kv330fs08h
28 Sep 20
Prospectus supplement with pricing info
4:56pm
8-K
EX-99.1
gsp 2o5mjn
25 Sep 20
Entry into a Material Definitive Agreement
5:25pm